Literature DB >> 17692632

Algorithm for prioritization of patients on the waiting list for liver transplantation.

M Gambato1, M Senzolo, D Canova, G Germani, S Tomat, A Masier, F P Russo, E Perissinotto, G Zanus, U Cillo, P Burra.   

Abstract

UNLABELLED: Prioritization of patients on the waiting list (WL) for OLT is still a critical issue. Numerous models have been developed to predict mortality before and after OLT. AIM: The aim of the study was to prospectively evaluate cirrhotics with and without hepatocellular carcinoma (HCC) undergoing orthotopic liver transplantation (OLT) severity of liver disease on the WL and at transplant, mortality on the WL and after OLT, and their correlations.
MATERIALS AND METHODS: An algorithm based on seven patient variables (MELD, CTP, UNOS, HCC, BMI, waiting time, age) was created by software dedicated to prioritize patients on the waiting list.
RESULTS: We evaluated 118 patients including 75 men and 43 women of age range 19 to 66 years, who underwent OLT from July 2004 to June 2006. Mean CTP and MELD at listing were 8.44 (range 6-12) and 13 (range 2-24), respectively. Overall mortality on the WL at 24 months was 13%, which was significantly higher among patients with MELD > 25 compared to patients with MELD 0 to 15 (P < .0001) or MELD 16 to 25 (P = .0007) at listing. Mean MELD at OLT was 15 (range 7-36), which was significantly lower in patients with than without HCC (MELD 12 vs 16; P = .0003). Six hundred-day patient survival was significantly lower among patients with MELD > 25 compared to patients with MELD < 25 at OLT (P = .017), whereas no difference in survival was observed between patients with and without HCC.
CONCLUSIONS: The sickest patients are characterized by high mortality both on the waiting list and after liver transplantation. Patients with HCC are transplanted in better condition compared to patients without HCC with the same survival.

Entities:  

Mesh:

Year:  2007        PMID: 17692632     DOI: 10.1016/j.transproceed.2007.05.059

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Albumin-to-bilirubin score for assessing the in-hospital death in cirrhosis.

Authors:  Lichun Shao; Bing Han; Shu An; Jiaxin Ma; Xiaozhong Guo; Fernando Gomes Romeiro; Andrea Mancuso; Xingshun Qi
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-07

2.  The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics.

Authors:  Iftikhar Haider Naqvi; Abu Talib; Khalid Mahmood; Rida Abidi; Saiyeda Nayema Zehra Rizvi
Journal:  Prz Gastroenterol       Date:  2019-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.